ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,942.47
      1.26%
      US Tech 100
      20,762.73
      1.73%
      Dow Jones
      42,732.13
      0.80%
      Brent Oil
      76.495
      0.00%
      Bitcoin
      97,586.89
      -0.53%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. UK
      5. LSE

      6. Faron Pharmaceuticals Oy (FARN) Quote

      Faron Pharmaceuticals Oy

      Faron Pharmaceuticals Oy (FARN)

      LSE
      205.00
      -5.00
      (-2.38%)
      Closed January 04 11:30AM
      Delayed by 15 minutes

      Empower your portfolio: Real-time discussions and actionable trading ideas.

      Premium

      Key stats and details

      Current Price
      205.00
      Bid
      200.00
      Ask
      210.00
      Volume
      13,727
      205.00 Day's Range 210.00
      89.00 52 Week Range 310.00
      Market Cap
      214.471M
      Previous Close
      210.00
      Open
      210.00
      Last Trade
      5000
      @
      208
      (O)
      Last Trade Time
      Financial Volume
      -
      VWAP
      -
      Average Volume (3m)
      20,155
      Shares Outstanding
      104,620,000
      Dividend Yield
      -
      PE Ratio
      -6.93
      Earnings Per Share (EPS)
      -0.3
      Revenue
      -
      Net Profit
      -30.94M

      About Faron Pharmaceuticals Oy

      Sector
      Pharmaceutical Preparations
      Industry
      Pharmaceutical Preparations
      Website
      www.faronpharmaceuticals.com
      Headquarters
      Turku, Fin
      Founded
      -
      Faron Pharmaceuticals Oy is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker FARN. The last closing price for Faron Pharmaceuticals Oy was 210p. Over the last year, Faron Pharmaceuticals Oy shares have traded in a share price range of 89.00p to 310.00p.

      Faron Pharmaceuticals Oy currently has 104,620,000 shares outstanding. The market capitalization of Faron Pharmaceuticals Oy is £219.70 million. Faron Pharmaceuticals Oy has a price to earnings ratio (PE ratio) of -6.93.

      Ask ADVFN Intelligence (AI)

      FARN Latest News

      More News

      Faron Pharmaceuticals Oy Faron’s Financial Calendar for 2025

      Faron Pharmaceuticals Oy 13 December 2024   Faron Pharmaceuticals Ltd.   ("Faron" or "the Company")   Faron's Financial Calendar for 2025   Company announcement, 13 December 2024 TURKU...

      December 13 2024
      RNS Regulatory News

      IN BRIEF: Faron Pharmaceuticals shares up as presents data on Bexmab

      cals PLC on Tuesday - Turku, Finland-based developer of cancer immunotherapies - Presents full analysis of positive ph ...

      December 10 2024
      Alliance News

      Faron presents BEXMAB data at ASH Annual Meeting

      Faron presents BEXMAB data at ASH Annual Meeting PR Newswire TURKU, Finland, Dec. 10, 2024 Faron Pharmaceuticals Ltd. ("Faron" or "the Company") Faron Presents Full Analysis of Positive Phase 2...

      December 10 2024
      PR Newswire (US)

      Faron Pharmaceuticals Oy Faron presents BEXMAB data at ASH Annual Meeting

      Faron Pharmaceuticals Oy 10 December 2024   Faron Pharmaceuticals Ltd.   ("Faron" or "the Company")   Faron Presents Full Analysis of Positive Phase 2 Interim Data from BEXMAB Trial at the...

      December 10 2024
      RNS Non-Regulatory

      Faron Pharmaceuticals Oy Interactions with UK Regulatory Authorities

      Faron Pharmaceuticals Oy 02 December 2024   Faron Pharmaceuticals Ltd.   ("Faron" or "the Company")   Faron Announces Positive Update on Recent Interactions with UK Regulatory Authorities...

      December 02 2024
      RNS Non-Regulatory

      Faron announces promising findings from blood cancer drug trial

      Faron Pharmaceuticals Ltd on Wednesday reported positive data from an ongoing trial on patients receiving a new treat ...

      November 27 2024
      Alliance News

      Faron Pharmaceuticals Oy Positive Phase 2 Interim Results from BEXMAB Trial

      Faron Pharmaceuticals Oy 27 November 2024   Faron Pharmaceuticals Ltd.   ("Faron" or "the Company")   Inside Information: Faron Announces Positive Phase 2 Interim Results from BEXMAB Trial to...

      November 27 2024
      RNS Regulatory News

      Faron Pharmaceuticals Oy Targeting Soluble Clever-1 for Autoimmune Diseases

      Faron Pharmaceuticals Oy 11 November 2024   Faron Pharmaceuticals Ltd.   ("Faron" or "the Company")    Pipeline Update: Targeting Soluble Clever-1 for Autoimmune Diseases   Press release, 11...

      November 11 2024
      RNS Non-Regulatory

      Faron Pharmaceuticals Oy Shareholders’ Nomination Board

      Faron Pharmaceuticals Oy 05 November 2024   ("Faron" or "the Company")    Composition of Faron Pharmaceutical's Shareholders' Nomination Board   Company Announcement, 5 November 2024   TURKU...

      November 05 2024
      RNS Regulatory News

      Faron Pharmaceuticals Oy Faron’s Capital Markets Day 2024

      Faron Pharmaceuticals Oy 22 October 2024   Faron Pharmaceuticals Ltd.   ("Faron" or "the Company")    Faron's Capital Markets Day 2024 - BEXMAB follow-up data and update on drug development...

      October 22 2024
      RNS Regulatory News
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      13520.5882352941170210169.516174205.28212282DE
      42010.810810810818521016516231180.56050667DE
      12-10-4.6511627907215215142.520155177.51829732DE
      26111.5119.25133689893.523392.537461162.24210381DE
      52-105-33.87096774193103108939272150.32232439DE
      156-65-24.0740740741270392.58921426195.5603524DE
      260-70-25.45454545452755608931639293.63490428DE

      FARN - Frequently Asked Questions (FAQ)

      What is the current Faron Pharmaceuticals Oy share price?
      The current share price of Faron Pharmaceuticals Oy is 205.00p
      How many Faron Pharmaceuticals Oy shares are in issue?
      Faron Pharmaceuticals Oy has 104,620,000 shares in issue
      What is the market cap of Faron Pharmaceuticals Oy?
      The market capitalisation of Faron Pharmaceuticals Oy is GBP 219.7M
      What is the 1 year trading range for Faron Pharmaceuticals Oy share price?
      Faron Pharmaceuticals Oy has traded in the range of 89.00p to 310.00p during the past year
      What is the PE ratio of Faron Pharmaceuticals Oy?
      The price to earnings ratio of Faron Pharmaceuticals Oy is -6.93
      What is the reporting currency for Faron Pharmaceuticals Oy?
      Faron Pharmaceuticals Oy reports financial results in EUR
      What is the latest annual profit for Faron Pharmaceuticals Oy?
      The latest annual profit of Faron Pharmaceuticals Oy is EUR -30.94M
      What is the registered address of Faron Pharmaceuticals Oy?
      The registered address for Faron Pharmaceuticals Oy is JOUKAHAISENKATU 6, INTELLIGATE, TURKU, FIN-20520
      What is the Faron Pharmaceuticals Oy website address?
      The website address for Faron Pharmaceuticals Oy is www.faronpharmaceuticals.com
      Which industry sector does Faron Pharmaceuticals Oy operate in?
      Faron Pharmaceuticals Oy operates in the PHARMACEUTICAL PREPARATIONS sector

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      TCFTheracryf Plc
      0.725p
      (38.10%)
      		7.56M
      NMTNeometals Ltd
      3.50p
      (27.27%)
      		346.81k
      SCHOScholium Group Plc
      44.00p
      (25.71%)
      		30.65k
      FABFusion Antibodies Plc
      10.15p
      (24.54%)
      		3.34M
      PYXPyx Resources Limited
      3.49p
      (22.24%)
      		8.43k
      TM1Technology Minerals Plc
      0.125p
      (-24.24%)
      		37.21M
      QUIZQuiz Plc
      0.70p
      (-18.60%)
      		3.67M
      SYMESupply@me Capital Plc
      0.003p
      (-17.81%)
      		168.35M
      OBDOxford Biodynamics Plc
      1.20p
      (-14.29%)
      		827.83k
      ZENZenith Energy Ltd.
      5.25p
      (-13.93%)
      		5.39M
      TRPTower Resources Plc
      0.0395p
      (5.33%)
      		539.51M
      CPXCap-xx Limited
      0.1825p
      (1.39%)
      		494M
      NTVONativo Resources Plc
      0.0019p
      (0.00%)
      		320.16M
      DGIDg Innovate Plc
      0.0225p
      (-13.46%)
      		208.21M
      ENETEthernity Networks Ltd
      0.1125p
      (2.27%)
      		207.56M

      Discussion

      View Full Feed
      Hikerbc Hikerbc 3 minutes ago
      That bail-in concept is gross, untterly !
      AMC
      biotechinvestor1 biotechinvestor1 3 minutes ago
      He is a permabear. He can't help it. Same with Maumer. 

      They were proven wromg when halo was trading in single digits, teens, $20's, 30's, and low $40's. Read their posts going back to 2010 and you will see that there is always an underlying doom and gloom tone/forecast. But just beca
      HALO
      Investor2014 Investor2014 4 minutes ago
      Just drag and drop your file at the prompt. If it doesn't work update your stuff.

      This is my unpaid version:
      I’m ChatGPT, version 2! This means I have enhanced reasoning abilities, improved understanding of nuanced contexts, and better tools to assist you. Let me know how I ca
      AVXL
      al44 al44 4 minutes ago
      Read the room!

      By Kevin Finn

      How unaware must a governor of a proclaimed sanctuary state be to tout imagined strides in subway safety just hours after a sleeping woman was set ablaze and burned to death by an illegal immigrant? How heedless of their own constituents mus
      glenn1919 glenn1919 4 minutes ago
      syrs..............https://stockcharts.com/h-sc/ui?s=syrs&p=W&b=5&g=0&id=p86431144783
      SYRS
      The_Edge The_Edge 5 minutes ago
      if you read the financial report for ending sept 30, 2024 cash position is 29,578,653 of that is customer funds of 21,576,937..
      not likely able to use customer funds for any share buyback plan ... I'm guessing these funds are under Alchemy Markets Limited
      Like everything else here ..
      FDCT
      macnai macnai 6 minutes ago
      https://www.semiconductor-digest.com/2025-ai-momentum-continues/
      POET
      Golden Cross Golden Cross 6 minutes ago
      $ILLR ✨Triller is Building a Digital Economy Powerhouse:
      $4 Billion Merger Now Complete. Triller aims to accelerate innovation, drive rapid growth, and expand their market presence globally🌐
      https://youtube.com/watch?v=u3KN4o-BBAI

      [yt]u3KN4o-BBAI[/yt]
      BBAI ILLR
      glenn1919 glenn1919 6 minutes ago
      wkhs..............https://stockcharts.com/h-sc/ui?s=wkhs&p=W&b=5&g=0&id=p86431144783
      WKHS
      Golden Cross Golden Cross 6 minutes ago
      $ILLR ✨Triller is Building a Digital Economy Powerhouse:
      $4 Billion Merger Now Complete. Triller aims to accelerate innovation, drive rapid growth, and expand their market presence globally🌐
      https://youtube.com/watch?v=u3KN4o-BBAI

      [yt]u3KN4o-BBAI[/yt]
      BBAI ILLR
      misterfishman misterfishman 6 minutes ago
      I wonder if this expert market chit stock will make it out of expert market this year.
      NNRX
      mauismart mauismart 6 minutes ago
      I see they are out in force over the weekend. Who is paying them for their dribble? Are they going to run the short sale a ro b program next week to get shares? They need to look in the mirror when one of their relatives needs this med. You can buy cigarettes and alcohol that will give you cancer an
      AVXL
      Stock_Barber Stock_Barber 7 minutes ago
      1:22 in the morning... "Last call" must have been1 a.m.?

      Your 24/7/365 pumping / attacking critics is working wonderfully, eh?


      ih.advfn.com/p.php?pid=chartscreenshot&u=ctSLXkzvTImrn5Y%2F96l%2FfHBbhIK7e3QcWTCwi8nHyMw%3D
      DBMM
      glenn1919 glenn1919 7 minutes ago
      azi............................https://stockcharts.com/h-sc/ui?s=azi&p=W&b=5&g=0&id=p86431144783
      AZI
      Investor2014 Investor2014 8 minutes ago
      Yes in that scenario Anavex would most definitely have lost momentum as compared to their initial statement of initiating a confirmatory trial in parallel with considering filing for approval based on the P2b/3 trial. I wish Anavex had done that confirmatory trial instead of filing only in the hope
      AVXL
      misterfishman misterfishman 8 minutes ago
      Well said and true. The patient ones will win out in the end.
      IGPK
      glenn1919 glenn1919 9 minutes ago
      IMMX..........................https://stockcharts.com/h-sc/ui?s=IMMX&p=W&b=5&g=0&id=p86431144783
      IMMX
      Bubae Bubae 9 minutes ago
      I have to admit that I have had to educate myself about these reverse takeovers. Looks to me like Mexedia S p A was looking for a path into the U.S. trading market and found a worthless, essentially a shell company in Raadr to do it. This company has been designated as a shell risk on the OTC site.
      RDAR
      NASDAQ2020 NASDAQ2020 10 minutes ago
      2nd shift doubles production
      ELTP
      sumbuysumsell sumbuysumsell 11 minutes ago
      Apparently we are using different versions of ChatGPT. Excerpts only at this end. The complete article was declared too long.
      Q-How does a user update PDF files to ChatGPT?
      A-Currently, ChatGPT doesn't have the ability to accept or process PDF files directly. However, you can still ge
      AVXL
      Mcfish Mcfish 12 minutes ago
      BS
      LWLG
      DiscoverGold DiscoverGold 13 minutes ago
      Cattle prices jump to a fresh all-time high
      By: Barchart | January 3, 2025

      • Cattle prices jump to a fresh all-time high.

      pbs.twimg.com/media/GgZqnITa0AAULVD?format=jpg&name=large

      https://x.com/Barchart/status/1875303570825965753 Read Full

      Your Recent History

      LSE
      FARN
      Faron Pharmaceuticals Oy
      TSX
      FEBB.F
      First Trust Vest US Equi...
      AMEX
      APT
      Alpha Pro Tech
      LSE
      BOY
      Bodycote
      Delayed Upgrade Clock

      Go Ad-Free

      Subscribe to Ad free and enjoy an ad-free experience

      No Ads

      Try Now

      Keep the Ads